Scientists have developed a new type of gene editing CRISPR system, called CRISPR-Cas3, which can efficiently erase long stretches of DNA from a targeted site in the human genome, with the potential to seek out and erase such ectopic viruses as herpes simplex, Epstein-Barr, and hepatitis B.